🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to announce reviewer incentives AJG - The American Journal of Gastroenterology! We appreciate the hard work of scientific review. 5 highly rated reviews earns a free membership ACG! Check out our menu of incentives: gi.org/reviewer-incen… Jasmohan Bajaj Amy Oxentenko MD

Gastroenterologists and hepatologists, what are your feelings on the stethoscope? Important diagnostic tool or merely an accessory to make you "look like a doctor" (see Clooney Fig 1). This AJG - The American Journal of Gastroenterology #RedSection piece may make you rethink your answer. journals.lww.com/ajg/Fulltext/9…

It's #WorldIBSDay2023 so the Red Journal is sharing ACG clinical guideline on the management of #IBS #IrritableBowelSyndrome 📕bit.ly/ACG-Guideline-…

Excellent initiative to start this peer-reviewed, open access, journal by Canadian IBD clinicians. Thanks to the editorial board Talat Bessissow Jeffrey McCurdy MD PhD Cynthia Seow Remo Panaccione, MD, FRCPC and the generous support from Takeda canadianibdtoday.com

New milestone in CD therapy 👍

Remo Panaccione, MD, FRCPC Crohn's and Colitis Canada Eric Benchimol Dr. Stephanie Coward Joey Windsor, PhD I’m so proud of everyone who worked together to produce Crohn’s and Colitis Canada 2023 IBD Impact Report. This is the executive summary of the report published in JCAG today: academic.oup.com/jcag/advance-a…

1/n On behalf of co-authors, excited to share our new GEM Project Study Gastroenterology, which shows evidence for the first time that gut microbiome composition is associated with future risk of Crohn’s disease in a prospective cohort following 3483 healthy first-degree relatives

Comparative effectiveness of biologic therapies in preventing penetrating complications in #Crohns Collab Jeffrey McCurdy MD PhD & amazing Center for Administrative Database Research @WashUi2db Test Account @WUGastro @IbdWustl uOttawa | Faculté de médecine, Faculty of Medicine sciencedirect.com/science/articl…

Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe #Ulcerative Colitis: A Systematic Review and Network Meta-Analysis AJG - The American Journal of Gastroenterology Christopher Ma MD MPH Vipul Jairath MBChB DPhil #SiddharthSingh #IBD pubmed.ncbi.nlm.nih.gov/36976548/

Remarkable TheLiverDoc has had his account suspended in India for his work on preventing drug induced liver injury from herbal supplements. The company has gotten X to this. This is censorship Akin to having a beer company cancel an account that publishes on #cirrhosis

Our Fall 2023 Call for Research Proposals has been announced! We're funding up to 2 proposals at a maximum of 100k each. Submissions are due January 5th, 2024. For more details, visit: circ-ccrm.ca/investigator-i… Neeraj Narula Vipul Jairath MBChB DPhil Talat Bessissow Harminder Singh Christopher Ma MD MPH

In the 📕#RedJournal: Postendoscopy Care for Patients Presenting With Esophageal Food Bolus Impaction: A Population-Based Multicenter Cohort Study Guo, et al. 👉 bit.ly/490WTQ5 Milli Gupta Christopher Ma MD MPH

avenuecalgary.com/top-40-under-4… Congratulations to Dr. May Choi maychoi from the division of rheumatology.

1/7 A friend and mentor is celebrating a special birthday this week. I have been fortunate enough to have known him for over 30 years and I owe much of my success to him . It allowed me to reflect on who Brian Feagan the man truly is Vipul Jairath MBChB DPhil Bruce E. Sands Florian Rieder

A new and important study by Tom Goodsall Rob Bryant Christopher Ma MD MPH and many great colleagues from 🇦🇺 & 🌎 on #intestinalultrasound and reliability, cghjournal.org/article/S1542-… in CGH. I am delighted for the collaboration and to be involved as an IBUS InternationalBowelUS

💥News from the #STARConsortium #WeTheFibrosisLab💥 Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease | Radiology pubs.rsna.org/doi/10.1148/ra… - Important for Clinical Trial Endpoints in Stricturing Crohn’s disease Miguel Regueiro Christina Ha MD Meena Bewtra

Excited to share this review from our group about RCTs in IBD rdcu.be/dWoYg - one day, we might even have more trial acronyms than cardiologists! Vipul Jairath MBChB DPhil Laurent Peyrin-Biroulet Remo Panaccione, MD, FRCPC Silvio Danese Bruce E. Sands

#UEGWeek #ARTEMIS-UC #TL1A #Tulisokibart in mod-severe UC my_UEG ✅Maintenance of response at wk52 in those who responded wk12 w a dose effect: 🌟Clinical response 68% 🌟C Remission 48% 🌟Endo remission 48% 🌟⬇️⬇️FCP, CRP 🌟No new safety signal

With more choices, how do different therapies in UC stack up? authors.elsevier.com/c/1jxcc5UiFSkm… Work led by my friend Talat Bessissow examines the comparative efficacy of different advanced therapies for moderate-to-severe UC McGill University CGH Vipul Jairath MBChB DPhil Neeraj Narula

Great program so congrats to Flo, Tina and the rest of the steering committee. Really nice interacting with the future generation of IBD-ologists. Look forward to the 🇨🇦edition coming next month. And continued meetings building alliances within the #IBD community in North America